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Abstract
Background: The present study was designed to evaluate the potential of isoquercetin-based cream formulation
on scald burn wound injury in rats.
Methods: Four isoquercetin-based cream formulations viz. 0.01, 0.02, 0.04, and 0.06 % w/w were prepared. Cream
base and standard anti-burn cream containing silver sulfadiazine were also used for comparison. Scald burn was
given to rats by pouring water at 90 °C on a shaved dorsal area of 20 mm2. Deep second-degree burn injury was
produced which was evaluated for the next 21 days for the percentage of wound contraction and period of
epithelialization. On day 21, the rats were sacrificed and histopathological slides were prepared using hematoxylin-eosin
staining. Burned tissue was also screened for levels of oxidative stress using thiobarbituric acid reactive species (TBARS)
and reduced glutathione (GSH) estimation.
Results: There was a significant increase in the percentage of wound contraction and a significant decrease in the period
of epithelialization in isoquercetin-based cream-treated groups as compared with the control group. However, most
significant results were obtained with isoquercetin 0.06 % w/w cream. Histologically, isoquercetin 0.06 % w/w cream
treatment resulted in almost complete re-epithelialization and re-structuring of the wound tissue. There was a significant
rise in TBARS and a decrease in GSH levels in the burn injury group which was reversed to a major extent by the
application of isoquercetin-based cream.
Conclusions: The results indicate the wound healing potential of isoquercetin-based cream. Tissue biochemical studies
indicate towards a possible role of free radical scavenging in the observed effects of isoquercetin in wound healing.
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Background
Burns can be defined as a detriment to the skin prompted
by diverse sources, most frequently, extravagant heat or
caustic chemicals. Burn injury may be distinguished as a
kind of inflammation beneath the stratum corneum of the
skin, which can either progress to extemporary healing or
can deteriorate to further necrosis, contingent on the
approach to treatment [1, 2].
Thermal burn injury tends to be the most common
devastating trauma that emanates in either disability or
death of burn patients [3]. Reactive oxygen species have
been implicated in thermal burns that contribute to lipid
peroxidation and other inflammatory response [4–6]. In
contempt of the exploration of immense antiseptics,
healing of burn wound still remains a challenge to mod-
ern medicine [7]. Current treatment strategies usually
rely on topical application of the medicament with an
aim to intensify wound healing, minimize inflammatory
response, and most importantly halt the opportunistic
infections that are commonly associated with severe
wound injuries [8].
The most extensively used topical agent for burn injury
includes silver sulfadiazine (SSD) 1 % cream, probably
owing to its antimicrobial efficacy [9]. Regardless of this,
the most significant clinical adverse effect of silver topical
agent is the delayed wound healing along with other
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delineated adverse reactions such as resistance to silver
sulfadiazine, renal toxicity, and leucopenia, therefore con-
firming that it should not be used on extensive wounds
for extended periods [10, 11].
Morus alba L. (Mulberry) belonging to the Moraceae
family, commonly known as white mulberry, has been
reported to possess a wide number of bioactive flava-
noids including quercetin, rutin, and isoquercetin.
Isoquercetin being superior in concentration is the
main anti-oxidant component of M. alba leaves that
have been reported to manifest myriad of activities
such as anti-inflammatory [12], anti-oxidant [13–15],
antimicrobial [16], reducing lipid peroxidation both
in vivo and in vitro [17], anti-diabetic activity [18],
cytotoxic activity [19], and anti-hyperuricemic activity
[20]. Despite the established anti-oxidant property of
isoquercetin through diverse research [12–15], the
potential of isoquercitrin in burn injury is not yet
scrutinized. Therefore, the present study has been de-
signed to evaluate the potential of isoquercetin-based
cream preparations on scald burn injury in rats.
Methods
Animals
Wistar albino rats of either sex weighing 175 ± 25 g were
employed in the present study. Animals were fed with
standard laboratory feed (Kisan Feeds Ltd., Chandigarh,
India) and water ad libitum. They were housed in the
departmental animal house and were exposed to stand-
ard conditions of temperature (23 ± 2) °C, humidity of
50 ± 5 %, and natural cycles of light and dark. The ex-
perimental protocol was approved by the Institutional
Animal Ethics Committee, and the care of the animals
was carried out as per the guidelines of the Committee
for the Purpose of Control and Supervision of Experi-
mental Animals (CPCSEA), Ministry of Environment
and Forests, Government of India (Reg. No.– 1753/PO/
a/14/CPCSEA).
Experimental protocol
The animals were divided into eight groups, each con-
sisting of five rats. The duration of protocol was 21 days.
The groups were assigned as follows:
Group 1—normal/sham group
Group 2—burn injury/control group
Group 3—cream base-treated group
Group 4—0.01 % soquercetin-based cream-treated group
Group 5—0.02 % isoquercetin-based cream-treated group
Group 6—0.04 % isoquercetin-based cream-treated group
Group 7—0.06 % isoquercetin-based cream-treated group
Group 8—silver sulfadiazine (standard) cream-treated
group
Experimental procedure
Group 1—normal/sham control group: Animals in this
group were just made to undergo the shaving procedure
on the ear and then were kept undisturbed for the whole
study protocol.
Group 2—burn injury/control group: Animals were given
scald burn injury. Animals were restrained in the rat
holder, and 2 cm of the area on the back of the rats was
carefully shaved to expose the skin. Hot water (90 °C) was
poured over the shaved area for 10 s. This heat exposure
caused a uniform second-degree burn on the skin.
The animals were immediately resuscitated with an
intra-peritoneal injection of ringer lactate solution
(2 ml/100 g body weight) to prevent spinal shock.
Group 3—cream base-treated group: Animals were
given scalding burn injury as discussed in group 2.
After the administration of ringer lactate solution,
cream base (without any medicament) was applied on
the affected area daily for a period of 21 days in an
approximate time period between 10:00 and 11:00 AM
with the help of a sterile gauge so as to cover the whole
burned area uniformly.
Group 4—0.01 % isoquercetin-based cream-treated
group: The same procedure was applied as described in
group 3, except that 0.01 % isoquercetin-based cream
was used instead of cream base.
Group 5—0.02 % isoquercetin-based cream-treated
group: The same procedure was applied as described in
group 3, except that 0.02 % isoquercetin-based cream
was used instead of cream base.
Group 6—0.04 % isoquercetin-based cream-treated
group: The same procedure was applied as described in
group 3, except that 0.04 % isoquercetin-based cream
was used instead of cream base.
Group 7—0.06 % isoquercetin-based cream-treated
group: The same procedure was applied as described in
group 3, except that 0.06 % isoquercetin-based cream
was used instead of cream base.
Group 8—silver sulfadiazine (standard) cream-treated
group: The same procedure was applied as described in
group 3, except that silver sulfadiazine cream
(Silverine®) isoquercetin-based cream was used instead
of cream base.
Preparation and formulation of isoquercetin-based cream
Firstly, 0.4 g of liquid white paraffin, 1.5 g of stearyl alcohol,
0.6 g of solid white paraffin, propyl paraben (0.003 g), and
isoquercetin (1, 2, 4, and 6 mg to formulate the desired
concentrations of 0.01, 0.02, 0.04, and 0.06 %, respectively)
were mixed and heated to a boiling point as aqueous phase.
Meanwhile, 6.032 g of deionized water was added to the
mixture of 1.4 g of propylene glycol, 0.06 g of sodium lauryl
sulfate, and 0.005 g methyl paraben. The mixture was
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heated as organic phase. Then, two separate phases were
mixed continuously while being treated to a constantly de-
creasing temperature. Thus, the uniform cream (10 g) was
produced after cooling. The cream was filled within easily
squeezable tube for application on the burned tissue of ani-
mals under experimental protocol. Our experimental re-
search and formulations were carried out under sterile
conditions. The final cream formulation was further tested
for sterility on agar-based culture media to check the possi-
bility of contamination with any pathogenic microbes.
Pharmacological parameters
Epithelialization period
Epithelialization period was monitored by noting the
number of days required for the eschar to fall off from
the burn wound surface without leaving a raw wound
behind.
Wound contraction
The size of lesions at 1, 11, and 21 days after burn injury
was well apparent and determined by following the pro-
gressive changes in wound area planimetrically, exclud-
ing the day of the wounding. The burn wound surface
area was then employed to calculate the percentage of
wound contraction, taking the initial size of the wound
200 cm2 as 100 %, by using the following equation:
Percentage of wound contraction
¼ Initial wound size−Specific day wound size
Initial would size
 100%
Histopathology of the skin tissue
On day 21 after burn injury, the animals were sacrificed
by decapitation after being anesthesized, burnt skin
tissue samples were collected for histopathological
examination. These tissue samples were fixed at 10 %
neutral buffered formalin solution, embedded in paraffin
wax, cut into 5-μm-thick sections, and stained with
hematoxylin-eosin stain for examination by light micros-
copy. The slides were examined under an Olympus CX
41 microscope (Japan).
Biochemical parameters
Estimation of thiobarbituric acid reactive species
The concentration of thiobarbituric acid reactive spe-
cies (TBARS) in tissues was estimated by the method of
Niehaus and Samuelson [21]. The tissue homogenate
was prepared with Tris-HCl buffer, pH 7.5, and 0.1 ml
of the supernatant was treated with 2 ml of (1:1:1 ratio)
TBA-TCA-HCl reagent (0.37 % w/v thiobarbituric acid,
0.25 N HCl, and 15 % w/v TCA); the mixture was then
kept in water bath for 15 min and further cooled and
centrifuged for 10 min at room temperature. The
absorbance was determined at 535 nm against the
reference blank. The values were expressed as milli-
moles per 100 g of tissues.
Estimation of reduced glutathione
The concentration of glutathione (GSH) in tissues was
estimated by the method of Ellman [22]. The supernatant
(1 ml) was treated with 0.5 ml of Ellman’s reagent and
3.0 ml of phosphate buffer (0.2 M, pH 8.0). Ellman’s re-
agent was prepared by solubilizing 19.8 mg of 5, 5′-dithio-
bisnitro benzoic acid in 100 ml of 0.1 % sodium citrate.
Finally, the absorbance was determined at 412 nm in a
UV 1800 spectrophotometer (Shimadzu Corporation,
Kyoto, Japan). Reduced GSH was expressed as milligrams
per 100 g of tissues.
Statistical analysis
The results were analyzed using one-way ANOVA followed
by Tukey’s post hoc analysis with p ≤ 0.05 considered
significant for all values.
Results
Tissue morphology
The burn wound tissue was characterized by pale white
zone of tissue necrosis and associated inflammatory
changes such as late edema and neutrophil infiltration.
Wound contraction
A significant increase in the percentage of burn wound
tissue contraction was prominent on day 1, day 11, and day
21 after burn injury (Table 1). The wound area was found
to decrease significantly in isoquercetin (0.01, 0.02, 0.04,
and 0.06 %w/v)-based cream-treated groups when com-
pared to burn injury control group. Moreover, on day 11,
the wound contraction was significantly greater in isoquer-
cetin 0.06 %w/v-based cream group as compared to other
groups for the same day (p < 0.05), which were compar-
able to the effect produced by silver sulfadiazine (stand-
ard drug)-treated group for the same day.
Wound epithelialization
The mean period of epithelialization was found to de-
crease significantly in the isoquercetin (0.01, 0.02, 0.04,
and 0.06 %w/v)-based cream-treated groups as com-
pared to that in the burn injury group (Table 2). The de-
crease in the mean period of epithelialization in the
isoquercetin 0.06 %w/v-based cream group was more
significant as compared to that in the silver sulfadiazine
(standard drug) group.
Wound tissue histopathology
The skin tissue sections stained with hematoxylin and
eosin stain were evaluated for histopathological changes
that included modifications in the inflammatory cells
and the magnitude of epidermal regeneration (Fig. 1).
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The granulation tissue sections of the isoquercetin-based
cream-treated groups showed marked improvement in
the wound healing in comparison with the control
group. The sham group presented no pathological
changes (Fig. 1a). The burn wound tissue sample exhib-
ited massive necrotic areas and severe hemorrhage in
dermis, and no epidermal regeneration was evident.
Apart from this, a large number of infiltrated poly-
morphonuclear (PMN) cells were seen that were a clear
indicator of severe inflammation (Fig. 1b). In the group
treated with cream base, there was very less epidermal
regeneration and PMN were also reduced with minute
focal re-epithelialization and disorganized epidermal layers
(Fig. 1c). In isoquercetin 0.01 and 0.02 %w/v-based
cream-treated groups, there was relative regeneration of
the epidermal layer along with fewer infiltrated PMN cells
as compared to the control group (Fig. 1d, e). In isoquer-
cetin 0.04 and 0.06 %w/v-based cream-treated groups, the
epidermis was completely regenerated and well-organized
with very slight PMN infiltration. The dermis layer was
also not distorted with clear dermis papillae and clear
demarcation between the epidermis and the dermis
(Fig. 1f, g). In SSD (standard) cream-treated group, the
epidermal regeneration was seen but with fewer epithelial
cell layers and relatively disorganized. The PMN infiltra-
tion was also reduced, but some mast cells were seen in
the dermis indicating mild inflammation (Fig. 1h).
TBARS and GSH
The burn injury resulted in a significant increase in the
wound tissue TBARS levels (Fig. 2) indicating a rise in
oxidative stress, and a decrease in the level of GSH (Fig. 3)
due to a compromising situation of a tissue anti-oxidant
mechanism. The burn wound tissue when treated with
isoquercetin-based cream depicted that there was a signifi-
cant decrease in the tissue TBARS levels and a significant
increase in GSH levels as compared to the control group.
However, the isoquercetin 0.04 and 0.06 %w/v-based cream
produced a more striking and significant response.
Discussion
The anomaly of free radical arbitrated cell injury is custom-
ary to the burn injury. Burn injury has been proclaimed in
the medical literature to provoke the formation and release
of oxidative free radicals and other pro-inflammatory medi-
ators that mainly contribute to lipid peroxidation [4–6].
The elevated lipid peroxidation level has been evident from
the thiobarbituric acid reaction [23–27]. Thus, it may be
suggested that the restoration of circulating volume by
aggressive fluid resuscitation as well as the compensation of
Table 1 Effect of cream base, silver sulfadiazine (standard), and isoquercetin-based creams on percentage of wound contraction in
various animal groups under study after scald burn injury in the period of 21 days
Treatment groups Percentage of wound contraction (mean ± standard deviations)
Day 1 Day 11 Day 21
Sham group – – –
Burn injury group 0 3 ± 0.21 13 ± 0.46
Cream base-treated group 0 5 ± 0.24 14 ± 0.38
Silver sulfadiazine cream-treated group 0 25a ± 1.23. 55a ± 1.42
0.01 % isoquercetin cream-treated group 0 15a ± 0.94 30a ± 1.17
0.02 % isoquercetin cream-treated group 0 17a ± 1.54 34a ± 1.28
0.04 % isoquercetin cream-treated group 0 18a ± 1.62 42a ± 1.44
0.06 % isoquercetin cream-treated group 0 24a ± 1.72 51a ± 1.42
Results are represented as mean ± standard deviation
aSignificant change in the mean value as compared to the burn injury group with p < 0.05
Table 2 Effect of different concentrations of isoquercetin-based
creams on period of epithelialization after scald burn injury in a
period of 21 days
Treatment groups Period of epithelialization in days
(mean ± standard deviations)
Sham group –



















Results are represented as mean ± standard deviation
aSignificant change in the mean value as compared to the burn injury group
with p < 0.05
bSignificant change in the mean value as compared to the silver sulfadiazine
cream-treated group with p < 0.05
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the loss of endogenous scavenging mechanisms may
collectively produce significant oxidative stress. Many
plants and their derivatives have demonstrated their
proficiency as anti-oxidants in scavenging as well as
curbing the release of the reactive oxygen species from
the ethno-pharmacological perspective [28–31]. The
M. alba leaf extract has been investigated for its anti-
oxidant property using various methods like the iron
(III)-reducing capacity, the total anti-oxidant capacity,
the DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scav-
enging activity, and an in vitro inhibition of ferrous
sulfate-induced oxidation of lipids [32]. Isoquercetin
being the main component of M. alba leaf was evalu-
ated for its potential in healing the scald burns.
The burn wound recovery was assessed in terms of per-
centage of wound contraction and development of epithe-
lial layer (period of epithelialization) after the eschar fell
from the wound. A significant increase in the percentage
of wound contraction in isoquercetin cream-treated group
indicates the potent healing effect exerted by isoquercetin
as compared to the control group. Furthermore, the der-
mal recovery of the tissue was also demonstrated in the
wound as there was a highly significant decrease in the
period of epithelialization in isoquercetin cream-treated
group. Furthermore, it was interesting to observe that the
decrease in the period of epithelialization in isoquercetin
cream-treated group was more marked than that of silver
sulfadiazine (standard)-treated group.
A
Normal/ Sham Group         
B
Burn Injury Group   
C
Cream base treated Group
D
0.01% Isoquercetin                
E




0.06% Isoquercetin     
H
Standard cream
Fig. 1 Representative histological slides of skin wound tissue of various groups on day 21 after burn injury. a Sham group with no histological
changes; b burn injury group slide is characterized by incomplete formation of epithelial layer, inflammatory tissue damage, and edema; c cream
base-treated group showing significant inflammatory damage and tissue edema; and d 0.01 % isoquercetin-based cream-treated group showing
significant healing of burned tissue. The cellular structure of dermal layers has been restored. The signs of necrosis have been limited to most extent, and
the tissue is devoid of any peri-vascular infiltration into tissue spaces. e 0.02 % isoquercetin-based cream-treated group showing more re-structuring and
re-organizing of burned tissue. The process of tissue necrosis appears halted and tissue spaces less widened. f 0.04 % isoquercetin-based cream-treated
group showing partial reformation of the epithelial layer with signs of tissue re-structuring and healing. g 0.06 % isoquercetin-based cream-treated group
showing almost complete formation and healing of the epithelial layer. Moreover, there is less edematous swelling of tissue. h Standard (silver sulfadiazine)
cream-treated group characterized by significant tissue repair and re-structuring with little edematous fluid
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Moreover, the isoquercetin cream-treated groups ex-
hibited a prominent decrease in the burn wound tissue
TBARS levels and a significant rise in GSH levels in
comparison with the burn injury group. An increase in
the tissue TBARS levels is a clear indicator of an in-
crease in the number of reactive oxygen species (ROS)
in the burn wound tissue. Furthermore, a decrease in
the GSH levels in the burn wound tissue points towards
a progressive decrease in the anti-oxidant capacity of the
skin tissue under the influence of burn injury.
The histopathological study of the burn wound tissue
clearly demonstrated the improvement in the tissue necro-
sis and associated inflammatory changes in different
concentrations of isoquercetin-based cream-treated groups.
However, significant injury repair and regeneration of epi-
thelium was evident in the 0.06 %w/v isoquercetin-based
Fig. 2 Changes in wound tissue TBARS after scald burn injury. The graph represents tissue levels of TBARS (mM/ml) in sham, burn injury control,
cream base-treated, silver sulfadiazine (standard)-treated, and different isoquercetin-based cream-treated groups. Results are represented as the
mean ± standard deviation; n = 6 per group. aSignificant change in the mean value as compared to the sham group with p < 0.05; bsignificant
change in the mean value as compared to the burn injury group with p < 0.05
Fig. 3 Changes in wound tissue GSH after scald burn injury. The graph represents tissue levels of GSH (mM/ml) of sham, burn injury control,
cream base-treated, silver sulfadiazine (standard)-treated, and different isoquercetin-based cream-treated groups. Results are represented as the
mean ± standard deviation; n = 6 per group. aSignificant change in the mean value as compared to the sham group with p < 0.05; bsignificant
change in the mean value as compared to the burn injury group with p < 0.05
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cream-treated group as compared to the burn injury group
and other groups as well indicating that higher concentra-
tions of isoquercetin are capable of reversing the burn
injury-induced morphological and biochemical as well as
micro-vascular changes implicated in necrosis.
The results indicate the potential of isoquercetin in
halting and to a much extent reversing the pathological
interplay of inflammatory mediators and associated pro-
oxidative pathways at the site of burn injury. The ob-
served actions could possibly be attributed to potent
anti-oxidant effect showed by isoquercetin as evident by
a significant decrease in the burn tissue TBARS levels in
the isoquercetin cream-treated groups. However, as burn
injury is always considered an acute dermatological in-
sult representing a plethora of oxidative changes within
a short span of time, therefore, isoquercetin-based for-
mulation could be of immediate use in burn injury so as
to suppress free radical production and oxidative stress
as early as possible. As a phytoconstituent, isoquercetin
is found in many plant species in different concentra-
tions which indicates the phytochemical importance of
this constituent in medicinal plants of higher order. We
are of the opinion that in future isoquercetin could be
favorably utilized by the pharmaceutical and cosmetic
industry for the development of anti-burn injury formu-
lations for possible use as supportive therapy to ongoing
and prevalent burn management therapeutic regime.
Conclusions
We can conclude that in a burn wound model in rats,
isoquercetin-based cream was found to shorten the healing
process both histopathologically and statistically as com-
pared to SSD and the control group. Through its evident
anti-oxidant and anti-inflammatory effects, isoquercetin
can be used as an adjunctive or alternative agent to existing
wound healing therapies in the future. However, wound
tissue healing is a multi-factorial process involving a
plethora of enzymes, receptors, and sub-molecular events.
Therefore, further research is needed for highlighting the
role of these processes and on the molecular mechanism of
observed action of isoquercetin.
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